Takeda Pharmaceutical Co Ltd
OTC:TKPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
Skeena Resources Ltd
F:RXF
|
CA |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Central Pattana PCL
SET:CPN
|
TH |
|
I
|
International Flavors & Fragrances Inc
F:IFF
|
US |
|
Basf Se
F:BAS
|
DE |
|
Primo Brands Corp
F:V76
|
US |
Dividends
Dividend Yield
Takeda Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Takeda Pharmaceutical Co Ltd
TKPHF have increased by 20%.
Payout Ratio
Takeda Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for TKPHF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TKPHF Price
Takeda Pharmaceutical Co Ltd
| Average Annual Return | -3.29% |
| Standard Deviation of Annual Returns | 16.48% |
| Max Drawdown | -30% |
| Market Capitalization | 8.1T USD |
| Shares Outstanding | 1 584 930 048 |
| Percentage of Shares Shorted |
N/A
|
